Sleep Disorders Trial, Recruiting (NCT06107517)

Sleep Disorders Trial, Recruiting NCT06107517 Sponsor: National University Hospital, Singapore Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06107517 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been assessed by their doctors as medically suitable for planned (non-emergency) heart bypass surgery (CABG)
People aged 21 years or older
People who speak English or Mandarin
People who are able to give their own consent to participate

Who may not be able to join:

People who speak languages other than English or Mandarin, as some of the study's assessments require one of these two languages
People who had a severe hearing impairment, severe cognitive impairment, a progressive neurological condition, or a psychological disorder before their illness or surgery
People who experience serious surgical complications, including heavy bleeding from surgical sites, severe infection causing the body to shut down that does not respond to maximum treatment, or who are in a critical condition with an expected survival of less than 48 hours
People who are pregnant
People who develop delirium (a sudden state of confusion) before the trial treatment has begun

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Su Ren Wong, National University Hospital, Singapore

Phone: +65-96280613

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06107517

Sponsor: National University Hospital, Singapore

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +65-96280613

More information: https://clinicaltrials.gov/study/NCT06107517

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been assessed by their doctors as medically suitable for planned (non-emergency) heart bypass surgery (CABG)
People aged 21 years or older
People who speak English or Mandarin
People who are able to give their own consent to participate

Who may not be able to join:

People who speak languages other than English or Mandarin, as some of the study's assessments require one of these two languages
People who had a severe hearing impairment, severe cognitive impairment, a progressive neurological condition, or a psychological disorder before their illness or surgery
People who experience serious surgical complications, including heavy bleeding from surgical sites, severe infection causing the body to shut down that does not respond to maximum treatment, or who are in a critical condition with an expected survival of less than 48 hours
People who are pregnant
People who develop delirium (a sudden state of confusion) before the trial treatment has begun

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National University Hospital, Singapore

Registry

ClinicalTrials.gov

Start date

8 January 2024

Est. completion

1 August 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Delirium; Delirium

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov